Peer-reviewedLicence not statedCytotechnology5 Nov 2026

Luteolin reduces cytarabine-resistant acute myeloid leukemia cell proliferation through the GSK3β/Nrf2 pathway

Tingting Cui¹
Chunyan Song¹
Xin Fan²
Wenbing Jin¹
Chunhui Yang¹
Yan Zhou¹
Zugang Xiao¹
Na Li¹

¹Department of Hematology, Kunming Children’s Hospital, The Affiliated Children’s Hospital of Kunming Medical University), Kunming, 650000 China
²Department of Burn and Plastic Surgery, Kunming Children’s Hospital, The Affiliated Children’s Hospital of Kunming Medical University), Kunming, 650000 China

Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis
Yichen Xu, Shuai Chen, Ruolin Zhang
DARU Journal of Pharmaceutical Sciences9 Nov 2026Peer-reviewedLicence not statedFull textGeneral medicinePMC
A predictive model for cytarabine syndrome-associated febrile episodes in children with acute lymphoblastic leukemia.
Zheng Wu, Lixiang Zhu, Yi Liu +5
Frontiers in pediatrics7 Oct 2026Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
COMPARISON OF EFFICACY THROUGH RETROSPECTIVE ANALYSIS OF SURVIVAL RATE BETWEEN AZACITIDINE AND LOW DOSE CYTARABINE IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
João Pedro Greca de Macedo BIASI, Júlia Riedel DERETI, Inácio Skraba SILVA +2
Hematology, Transfusion and Cell Therapy23 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
Fronto-temporal transcranial direct current stimulation reduces symptoms in treatment-resistant schizophrenia: a randomized sham-controlled trial
Milad Kadkhoda, Behnam Ghabel Damirchi, Fatemeh Sadat Raeisian +2
Scientific Reports3 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textNeurologyCrossref
Early Use of Molecular Diagnostics in the Emergency Department Reduces All-Cause Mortality in Patients with Pneumonia at Risk of Multidrug-Resistant Pathogens
Lorenzo Pelagatti, Francesca Mangani, Antonio Susanna +6
Diagnostics (Basel, Switzerland)1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{cui2026luteolin,
  title = {{Luteolin reduces cytarabine-resistant acute myeloid leukemia cell proliferation through the GSK3β/Nrf2 pathway}},
  author = {Tingting Cui and Chunyan Song and Xin Fan and Wenbing Jin and Chunhui Yang and Yan Zhou and Zugang Xiao and Na Li},
  journal = {Cytotechnology},
  year = {2026},
  month = nov,
  doi = {10.1007/s10616-026-01106-4},
  url = {https://doi.org/10.1007/s10616-026-01106-4},
}

RIS

TY  - JOUR
TI  - Luteolin reduces cytarabine-resistant acute myeloid leukemia cell proliferation through the GSK3β/Nrf2 pathway
AU  - Tingting Cui
AU  - Chunyan Song
AU  - Xin Fan
AU  - Wenbing Jin
AU  - Chunhui Yang
AU  - Yan Zhou
AU  - Zugang Xiao
AU  - Na Li
PY  - 2026
DA  - 2026/11/05
JO  - Cytotechnology
DO  - 10.1007/s10616-026-01106-4
UR  - https://doi.org/10.1007/s10616-026-01106-4
SN  - 0920-9069
SN  - 1573-0778
ER  -

Related

Cite